Effectiveness of Cochlear Implants in Adults with Sensorineural Hearing Loss
Total Page:16
File Type:pdf, Size:1020Kb
Technology Assessment Effectiveness of Cochlear Implants in Adults with Sensorineural Hearing Loss Technology Assessment Program Prepared for: Original: April 11, 2011 Agency for Healthcare Correction: June 17, 2011 Research and Quality 540 Gaither Road Rockville, Maryland 20850 i Effectiveness of Cochlear Implants in Adults with Sensorineural Hearing Loss Technology Assessment Report Project ID: AUDT0510 Original date: April 11, 2011 Correction date: June 17, 2011 * See Errata document for a summary of corrections. Tufts Evidence-based Practice Center Gowri Raman, M.D., M.S. Jounghee Lee, PhD Mei Chung, PhD, MPH James M. Gaylor, BA Srila Sen, M.A. (Editor) Madhumathi Rao, M.D., PhD Joseph Lau, M.D. Technical Consultants Dennis S. Poe, M.D. Associate Professor, Dept of Otology & Laryngology Harvard Medical School, Boston Marilyn W. Neault, PhD, CCC-A Director, Habilitative Audiology Program Children's Hospital, Boston ii This report is based on research conducted by the Tufts Evidence-based Practice Center under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. 290 2007 10055 1). The findings and conclusions in this document are those of the author(s) who are responsible for its contents; the findings and conclusions do not necessarily represent the views of AHRQ. No statement in this article should be construed as an official position of the Agency for Healthcare Research and Quality or of the U.S. Department of Health and Human Services. The information in this report is intended to help health care decision-makers; patients and clinicians, health system leaders, and policymakers, make well- informed decisions and thereby improve the quality of health care services. This report is not intended to be a substitute for the application of clinical judgment. Decisions concerning the provision of clinical care should consider this report in the same way as any medical reference and in conjunction with all other pertinent information, i.e., in the context of available resources and circumstances presented by individual patients. This report may be used, in whole or in part, as the basis for development of clinical practice guidelines and other quality enhancement tools, or as a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied. The technical consultant, Marilyn W. Neault, PhD, CCC-A discloses her affiliation as an Audiology Advisor on the Advisory Panel of Cochlear™ Americas. Her role in this report was limited to educating the Tufts-EPC on cochlear implantation and speech perception tests. All other investigators do not have any affiliation or financial involvement related to the material presented in this report. iii Peer Reviewers We wish to acknowledge individuals listed below for their review of this report. This report has been reviewed in draft form by individuals chosen for their expertise and diverse perspectives. The purpose of the review was to provide candid, objective, and critical comments for consideration by the EPC in preparation of the final report. Synthesis of the scientific literature presented here does not necessarily represent the views of individual reviewers. John K. Niparko, MD George T. Nager Professor of Otolaryngology-Head & Neck Surgery The Johns Hopkins University School of Medicine Baltimore, MD Sarah F. Poissant PhD Associate Professor University of Massachusetts Amherst Amherst, MA Susan Waltzman, PhD, CCC-A Marica F. Vilcek Professor of Otolaryngology and Co-Director NYU Cochlear Implant Center Affiliation New York, NY iv Table of Contents Table of Contents ........................................................................................................................v List of Tables ..............................................................................................................................v Abbreviations ............................................................................................................................ vi Executive Summary .............................................................................................................. ES-1 Introduction ................................................................................................................................1 Methods ......................................................................................................................................5 Results ...................................................................................................................................... 10 Discussion ................................................................................................................................. 43 Conclusion ................................................................................................................................ 45 Future research needs ................................................................................................................ 46 References ................................................................................................................................ 47 Appendix A. Description of abbreviations and relevant terms ................................................ A-1 Appendix B. Data Extraction Forms ........................................................................................ B-1 Appendix C. Search Strategy ................................................................................................... C-1 Appendix D. Summary Tables ............................................................................................... D-1 Appendix E. References of Included Studies ........................................................................... E-1 List of Tables ES Table 1. Strength of Evidence for Effectiveness of Cochlear Implants in Adults with Sensorineural Hearing Loss .........................................................................................................7 Table 1. Cochlear Implantation devices currently approved by the FDA .................................... 12 Table 2. Summary of baseline characteristics of the included studies for KQ2 ........................... 13 Table 3a. Summary results of speech perception measures in unilateral cochlear implants (quality-B studies) ..................................................................................................................... 15 Table 3b. Summary results of speech perception measures in unilateral cochlear implants (quality-C studies) ..................................................................................................................... 16 Table 4a. Summary results of health-related quality-of-life (generic) in unilateral cochlear implants (quality-B studies)....................................................................................................... 18 Table 4b. Summary results of health-related quality-of-life (generic) in unilateral cochlear implants (quality-C studies)....................................................................................................... 19 Table 5. Summary results of health-related quality-of-life (disease-specific) in unilateral cochlear implants .................................................................................................................................... 20 Table 6. Summary of baseline characteristics of the included studies for KQ 2a ........................ 26 Table 7. Results from studies evaluating the association between preoperative characteristics and outcomes ................................................................................................................................... 27 Table 8. Summary of baseline characteristics of the included studies for bilateral simultaneous and sequential cochlear implant ................................................................................................. 33 Table 9. Open-set sentences and multi-syllable tests in subjects with bilateral simultaneous cochlear implant ........................................................................................................................ 34 Table 10. Disease-specific health-related quality-of-life in subjects with bilateral simultaneous cochlear implant ........................................................................................................................ 35 Table 11. Open-set sentences tests in subjects with bilateral sequential cochlear implant ........... 38 Table 12. Health-related quality-of-life in subjects with bilateral sequential cochlear implant.... 39 v Abbreviations APHAB Abbreviated Profile of Hearing Aid Benefit ADIDS Adapted Deaf Identity Developmental Scale AQoL Assessment quality-of-life AzBio AzBio sentence test BKB Bamford-Kowal-Bench speech perception test BKB-SIN Bamford-Kowal-Bench Speech-in-Noise Test CID Central Institute for the Deaf sentences CNC Consonant-Nucleus-Consonant words CPA Centro de Pesquisas Audiológicas sentence recognition test CUNY City University of New York tests CVC Consonant-Vocal-Consonant dB HL Decibel Hearing Level EQ-5D EuroQoL 5 dimensions FDA Food and Drug Administration GBI Glasgow Benefit Inventory GHSI Glasgow Health Status Inventory HHIA Hearing Handicap Inventory for Adults HHIE Hearing Handicap Inventory for the Elderly HHQ Hearing Handicap Questionnaire HINT Hearing in Noise Test HINT-Q HINT sentences/speech in quiet HPS Hearing Participation